|Home | About | Journals | Submit | Contact Us | Français|
Conceived and designed the experiments: OD PC LO TD. Performed the experiments: CA SC SW CG RJ AMJ. Analyzed the data: OD PC LO TD CA SC SW. Contributed reagents/materials/analysis tools: OD PC LO TD. Wrote the paper: OD PC LO TD SC CA.
Synthesis of interferon-β (IFN-β) is an innate response to cytoplasmic infection with bacterial pathogens. Our recent studies showed that Listeria monocytogenes limits immune detection and IFN-β synthesis via deacetylation of its peptidoglycan, which renders the bacterium resistant to lysozyme degradation. Here, we examined signaling requirements for the massive IFN-β production resulting from the infection of murine macrophages with a mutant strain of L. monocytogenes, ΔpgdA, which is unable to modify its peptidoglycan. We report the identification of unconventional signaling pathways to the IFN-β gene, requiring TLR2 and bacterial internalization. Induction of IFN-β was independent of the Mal/TIRAP adaptor protein but required TRIF and the transcription factors IRF3 and IRF7. These pathways were stimulated to a lesser degree by wild-type L. monocytogenes. They operated in both resident and inflammatory macrophages derived from the peritoneal cavity, but not in bone marrow-derived macrophages. The novelty of our findings thus lies in the first description of TLR2 and TRIF as two critical components leading to the induction of the IFN-β gene and in uncovering that individual macrophage populations adopt different strategies to link pathogen recognition signals to IFN-β gene expression.
Detection of microbial pathogens by pattern recognition receptors, such as Toll-like receptors (TLRs) triggers innate immune responses as a first line of defense against infections –. Pathogen-associated molecular patterns (PAMPs) such as bacterial cell walls and their structural components induce a vast variety of biological effects in host organisms. The innate response against infection with intracellular pathogens includes the synthesis of type I IFNs (IFN-I). Whereas this cytokine family generally protects against viruses, its impact on bacterial infections can be either detrimental or advantageous for the host organism .
Listeria monocytogenes is a bacterial pathogen which replicates in the cytoplasm of infected cells. Cytosolic pattern recognition receptors (PRRs) respond to cytosolic bacterial products and contribute to the induction of the innate immune response , . Previous studies in bone marrow-derived macrophages (BMM) and epithelial cells show that in these cell types the synthesis of IFN-I in response to infection with L. monocytogenes is independent of TLRs and their adapters, relying exclusively on signals originating from cytosolic sensors –. DNA as well as cyclic dinucleotides released from lysed bacteria were suggested to function as the relevant L. monocytogenes PAMPs –. Several cytosolic proteins with the ability to sense pathogen-derived nucleic acids have recently been described –. Cytosolic recognition of L. monocytogenes causes the activation of the serine/threonine kinase TBK1 and the phosphorylation of its substrate transcription factors IRF3 and IRF7 , . Both IRF3 and IRF7 participate in the formation of an enhanceosome at the IFN-β promoter .
During uptake by host cells L. monocytogenes is exposed to plasma membrane and endosomal TLRs. Among these, TLR2 which recognizes lipotechoic acids and lipopeptides, contributes to the innate response against infection –. Reportedly, TLR2 signals through the interacting adapter proteins Mal/TIRAP and MyD88 and does not contribute to the synthesis of type I IFN in Listeria-infected BMM –. Signaling through TRIF, an adapter protein known to connect TLRs 3 and 4 with the IFN-I genes was similarly ruled out for Listeria-infected BMM .
In order to establish a successful infection, pathogens must survive host defense systems or else mitigate the activities of PRRs. Consequently, they have evolved to modify the structural components which normally trigger PRR responses. Bacterial PGN is a hetero-polymer consisting of alternating residues of β-1,4-linked N-acetylglucosamine and N-acetylmuramic acid to which a peptide chain is attached . Interestingly, L. monocytogenes modifies its PGN, with fifty per cent of the muropeptide composition being N-deacetylated . We previously reported that a PGN N-deacetylase gene, pgdA, is responsible for this modification . PGN deacetylation confers resistance to the action of lysozyme, one of the most important and widespread antimicrobial agents of the innate defense system, thus preventing degradation and release of immunostimulants. A strain of L. monocytogenes mutated in its ability to alter its PGN, ΔpgdA, is sensitive to lysozyme and induces an enhanced IFN-β response in macrophages compared to the isogenic parental strain .
The aim of the present study was to decipher the signaling pathways involved in this response to ΔpgdA infection. We reveal that IFN-β production in peritoneal macrophages requires TLR2 signaling and the TRIF adapter protein.
A L. monocytogenes pgdA mutant induced a much higher IFN-β response than the parental strain . To definitively establish a role for the peptidoglycan deacetylase PgdA in the down-regulation of IFN-β production, we complemented our original pgdA mutant with the wild-type gene and we measured IFN-β secretion of peptone elicited peritoneal macrophages (PEM) infected with wild-type EGDe, ΔpgdA and a complemented ΔpgdA strain (Fig. 1). Inactivation of pgdA led to a strong induction of IFN-β secretion in wild-type macrophages. In contrast, the complemented strain did not induce any massive IFN-β secretion, similar to wild-type EGDe. Thus, PgdA directly contributes to down-regulation of IFN-β production.
Consistent with our previous report measuring secretion of IFN-β protein in PEM, IFN-β mRNA synthesis induced by L. monocytogenes infection of PEM required TLR2 (Fig. 2A), while TLR2-deficient BMM showed no impairment in their synthesis of IFN-β mRNA (Fig. 2B). Moreover, IFN-β secretion was strongly reduced in tlr2−/− PEM infected with both the ΔpgdA mutant (Fig. 2C) and the complemented ΔpgdA strain (Fig. 2D), definitively establishing the TLR2 dependence of IFN-β production.
We next analyzed the pathways by which Listeria induces IFN-β. Our previous study and the above results strongly suggested the critical involvement of TLR2 . TLR2 signaling depends on Mal/TIRAP and MyD88 adaptor proteins. We had previously shown that MyD88 contributed to full IFN-β induction by Listeria . We then compared IFN-β production by wild-type and mal/tirap−/− macrophages infected with EGDe or ΔpgdA (Fig. 3A). Surprisingly, production of IFN-β was not decreased in infected macrophages deficient in Mal/TIRAP, indicating that the normal TLR2 adaptor Mal/TIRAP was not required for Listeria-mediated induction of IFN-β.
The adapter TRIF is employed by TLRs 3 and 4 to signal through the TBK1-IRF3/7-IFN-β pathway. There is no previous evidence of an association or functional interaction between TRIF and TLR2. In spite of this, the link between TRIF and the IRF pathway on the one hand, and the unusual employment of TLR2 for signaling to the IFN-β gene in PEM on the other suggested the possibility of a role for TRIF. To test this hypothesis we compared induction of IFN-β expression in wild-type and trif−/− PEM or BMM infected with EGDe or ΔpgdA strains. IFN-β induction strongly decreased in TRIF-deficient macrophages infected with any of the two Listeria strains compared to wild-type PEM, showing the requirement for TRIF (Fig. 3B). In contrast, BMM showed a TRIF-independent IFN-β production (Fig. S1).
The PEM used in our studies are recruited to the peritoneal cavity by injection of the sterile irritant proteose peptone. Hence they differ from BMM not only regarding their anatomical location, but also their partially inflammatory character. To distinguish which of these differences was responsible for the TLR2 and TRIF signaling pathways, we examined IFN-β production by resident PEM. Figure 3C demonstrates a requirement for TLR2 and TRIF by the resident macrophage population. Thus, location to the peritoneal cavity rather than inflammatory character determines the difference in signaling to the IFN-β gene between BMM and PEM.
To examine the role of TLR3, which uses TRIF to trigger IFN-β synthesis, we compared induction of IFN-β in wild-type and tlr3−/− PEM infected with EGDe or ΔpgdA strains. IFN-β production was decreased in TLR3-deficient PEM infected with EGDe or ΔpgdA (Fig. 4A). We also compared induction of IFN-β in wild-type and tlr4−/− PEM infected with EGDe or ΔpgdA strains, as TLR4 can mediate TRIF-dependent synthesis of IFN-β. In contrast to TLR3-deficient PEM, TLR4-deficient PEM did not show a decrease in IFN-β response to EGDe or ΔpgdA (Fig. 4B). Thus, IFN-β induction in response to Listeria infection relies in part on TLR3 and does not require TLR4.
Induction of IFN-β via TLR2 is no longer an exception. It has recently been shown that vaccinia virus-induced IFN-β production was dependent on TLR2 signaling and it was reported that this was occuring from late endosomes . To investigate if an intracellular localization was also required in the case of Listeria, we pretreated cells with cytochalasin D to prevent internalization and measured IFN-β secretion by macrophages infected with EGDe or the ΔpgdA mutant (Fig. 5A). In both cases, IFN-β induction was strongly reduced. Thus, internalization is critical for Listeria-mediated IFN-β production. We also used dynasore, a dynamin inhibitor and chloroquine, which inhibits endosome acidification, and measured IFN-β induction in macrophages infected with EGDe or the ΔpgdA mutant (Fig. 5B–C). IFN-β synthesis was strongly diminished by both dynasore and chloroquine treatments. Together, these results suggest that the TLR2-dependent IFN-β induction is triggered intracellularly.
In BMM rapid synthesis of IFN-β is entirely dependent on IRF3, but not on IRF7, whereas in bone marrow-derived myeloid DC IFN-β synthesis requires both IRF3 and IRF7 . We investigated the role of IRF3 and IRF7 in the production of IFN-β by PEM. To this end we infected irf3−/− and irf7−/− macrophages with EGDe or the ΔpgdA strains. Inactivation of IRF3 totally abrogated IFN-β mRNA induction in response to both strains (Fig. 6). IFN-β induction in IRF7-deficient macrophages was also strongly affected highlighting the important role of both transcription factors in response to Listeria infection (Fig. 6). PEM thus resemble bone marrow-derived myeloid DC, not BMM, in relation to their IRF requirement for Listeria-mediated IFN-β synthesis.
In addition to IRF3/7, NFκB contributes to the formation of the IFN-β enhanceosome , . We therefore examined the involvement of the NFκB pathway by measuring induced synthesis of an NFκB-dependent mRNA. IκB is an NFκB-dependent gene and thus a read-out for NFκB activation in response to Listeria infection. We measured the induction of IκB expression in PEM infected with EGDe or the ΔpgdA mutant. Both strains induced IκB expression and this required internalization as treatment with dynasore reduced the level of IκB induction (Fig. 7A). Degradation of the IκB protein was examined in PEM infected with EGDe by immunoblot using anti-IκB antibodies. IκB level was reduced rapidly after infection of wild-type PEM (Fig. S2A). In contrast, IκB degradation was not observed in tlr2−/− PEM infected with Listeria (Fig. S2B). Infection of wild-type, tlr2−/−and trif−/− macrophages with EGDe or ΔpgdA showed that both TLR2 and the adaptor were required for full induction of IκB mRNA in response to EGDe and ΔpgdA strains (Fig. 7B). These results suggest that TLR2 and TRIF contribute to NFκB activation. The comparison between EGDe and ΔpgdA strains showed that both caused similar magnitudes of IκB mRNA synthesis. Thus, the activation of NFκB by Listeria is independent of PgdA, suggesting that the increased IFN-β production after infection with ΔpgdA relies on activation of other transcription factors such as IRFs.
TLR2 or TRIF deficiency strongly reduced, but did not completely shut off IFN-β synthesis. This suggested a potential contribution of intracellular, nucleic acid-dependent pathways to IFN-β synthesis, particularly after infection with ΔpgdA. We therefore examined whether these pathways are able to signal in PEM.
Since inactivation of PgdA increases Listeria sensitivity to peptidoglycan-targeting antimicrobials such as lysozyme, and thus induces bacterial degradation, we measured the DNA and RNA released by EGDe and ΔpgdA strains following lysozyme exposure. As expected, ΔpgdA released significantly higher amounts of DNA and RNA than wild-type and complemented ΔpgdA strains, raising the possibility that both DNA and RNA could be involved in IFN-β production (Fig. 8A). We thus measured IFN-β induction in THP1 macrophages transfected with Listeria DNA, either undigested or treated with DNase. Intact but not DNase-treated DNA significantly induced IFN-β (Fig. 8B). Macrophages were then transfected with lysozyme-digested EGDe or ΔpgdA, either untreated or digested with DNase. Treatment with DNase significantly reduced IFN-β production (Fig. 8C). Taken together, these results show that Listeria DNA can induce IFN-β, strongly indicating that destruction of ΔpgdA bacteria intracellularly activates DNA sensors.
We had recently reported that a PGN modification involving a N-deacetylase gene, pgdA, was playing a key role in L. monocytogenes virulence . A ΔpgdA strain of L. monocytogenes which is unable to modify its PGN, was shown to be extremely sensitive to the bacteriolytic activity of lysozyme, normally found within macrophage vacuoles and its virulence was strongly attenuated . Furthermore, this mutant induced a much higher TLR2-dependent IFN-β response than the parental strain . We hypothesised that this unconventional IFN-β response induced by the pgdA mutant was due to an enhanced accessibility of bacterial cell wall components to TLR2. Here we have shown that IFN-β production requires bacterial internalization and is triggered by Mal/TIRAP-independent pathways which involve TLR2, TRIF, IRF3 and IRF7.
It was surprising to see a role for TLR2, as, based on results in BMM and epithelial cells, type I IFNs production is usually not known to result from TLR2 signaling –. Classical TLR2 signaling leads to NF-κB-dependent production of inflammatory cytokines . However, in support of an unconventional role for TLR2, recent studies reported roles for TLR2-dependent induction of IFN-β in response to vaccinia virus or synthetic ligands , . In the vaccinia virus study, a specific inflammatory monocyte population -Ly6Chi- was shown to be the source of IFN-β . In the present study we show that TLR2-dependent IFN-β synthesis is a property of both resident and recruited inflammatory PEM. Furthermore, the two previous studies documented that TLR2 activation of type I IFN responses to TLR ligands occurs within intracellular compartments, and that TLR2 signals from the phagosome in response to viral infection or synthetic TLR2 ligands , . These results challenged the view that TLR2 signals solely from the plasma membrane. In our experiments, pre-treatment of PEM with either cytochalasin D, an inhibitor of actin polymerization and thus internalization, dynasore, an inhibitor of the endocytic effector dynamin, or chloroquine, which inhibits endosome acidification , , significantly impaired the induction of IFN-β following Listeria infection, strongly suggesting that phagocytosis of L. monocytogenes and intracellular location of TLR2 trigger this response. These observations also correlate with our early hypothesis that the inflammatory response induced by ΔpgdA is due to an enhanced release or accessibility of bacterial cell wall components to TLR2.
Induction of the IFN-β gene was independent of the TLR adapter Mal/TIRAP, but, unexpectedly required the TLR3/4 adapter TRIF. Francisella tularensis has recently been shown to signal through TLR2 from the phagosome in a Mal/TIRAP independent manner , and it was shown that Mal/TIRAP is dispensable in TLR2 signaling at high concentrations of ligands . Thus our study reinforces the view that TLR2 can act independently from Mal/TIRAP. In addition our report suggests a synergy between a TLR2 pathway and TRIF, an adapter previously known to trigger the synthesis of pro-inflammatory cytokines and type I IFNs upon engagement of TLR3 and TLR4. TLR3 is known to bind viral dsRNA to induce secretion of type I IFN and lead to control of viral infections , , . To our knowledge Chlamydia muridarum is the only bacterium reported to induce a TLR3-dependent IFN-β response specifically in murine oviduct epithelial cells . We tested whether the dual requirement for TLR2 and TRIF resulted from a functional or physical interaction between TLR2 and TLR3. In fact, IFN-β production was reduced in TLR3-deficient macrophages, but significantly less so than in trif−/− PEM. Therefore, there is no evidence for a putative TLR2/TLR3 interaction. Another possibility to incorporate TRIF into the pathway stimulated in PEM by Listeria would be a cooperation of TLR2 and TLR4. This was ruled out by showing that Listeria-infected tlr4−/− PEM produced a similar amount of IFN-β as their wild-type counterparts. TRIF could possibly orchestrate an additional pathway. Along these lines, TRIF has recently been shown to be required for IFN-β synthesis by dendritic cells upon activation of the cytosolic receptor complex DDX1/DDX21/DDX36 by viral RNA .
Engagement of TLRs by various microbe-associated molecular patterns induces activation and translocation to the nucleus of NF-κB, IRF3, IRF7 and/or activator protein-1 (AP-1), which collaborate to induce transcription of type I IFNs . We addressed the role of these transcriptional activators in the IFN-β response to wild-type Listeria and ΔpgdA, and revealed that inactivation of IRF3 totally abrogated this response to both strains while IFN-β induction was significantly but not totally impaired in IRF7-deficient macrophages, indicating that both of these transcription factors are required for induction of IFN-β following infection with L. monocytogenes. We also assessed the involvement of NF-κB in this response using induction of the IκB gene as a readout. We observed an induction of IκB expression in macrophages which was similar after infection with EGDe or ΔpgdA. Thus, activation of NF-κB by Listeria is independent of PgdA, strongly suggesting that the elevated IFN-β production by the ΔpgdA mutant mostly relies on IRF3.
The increased IFN-β response to the ΔpgdA strain probably results from the fact that within the phagosome, its lysozyme-sensitive cell wall is degraded, releasing PAMPs able to interact with TLR2 and other PRRs, including cytoplasmic ones. As recent studies have highlighted novel DNA-sensing pathways in the induction of type I IFNs , –, , we thus also investigated the involvement of bacterial nucleic acids in the IFN-β induction, Firstly, we showed that inactivation of PgdA, which confers a higher susceptibility to lysozyme, leads to increased release of DNA. We then showed that DNA from L. monocytogenes can induce IFN-β expression in PEM, suggesting that this macrophage population employs cytoplasmic nucleic acid sensing similar to macrophages or macrophage lines derived from different anatomical locations , . Which -if any- of the recently described nucleic acid sensors are used by PEM for the recognition of Listeria DNA remains subject to future investigation. Nevertheless, other bacterial components could participate in IFN-β production upon infection with the ΔpgdA mutant. For example, the second messenger molecule cyclic diadenosine monophosphate (c-di-AMP), was shown to be secreted by Listeria multidrug efflux pumps triggering type I IFN response  and could be involved in the process.
In conclusion, this study describes a novel mechanism leading to induction of type I IFNs in which intracellular sensing plays an important role, ultimately showing how these different recognition pathways can synergise to induce innate immune responses which are required to control infection. In this regard cooperation between TLR2 and TRIF may reflect the need for convergence of the NF-κB and IRF pathways at the IFN-β promoter, with TLR2 being responsible mainly for NF-κB activation and TRIF being instrumental for activation of IRF3 and IRF7. By employing the strategy of PGN modification, L. monocytogenes can avoid immune detection by TLR and evade the innate immune response, thus enabling the infectious process to occur. It is important to recall that pgdA orthologs are found in other pathogenic bacteria, such as Streptococcus pneumoniae, Bacillus cereus, Bacillus anthracis and Helicobacter pylori, strongly suggesting that PGN N-deacetylation is a general mechanism evolved by microbes to escape from pattern recognition receptor-mediated immune recognition –.
L. monocytogenes EGDe (BUG1600, ATCC BAA-679), L. monocytogenes isogenic mutant ΔpgdA (BUG2288, ) and L. monocytogenes ΔpgdA complemented strain (BUG2382) were grown in brain heart infusion (BHI, Oxoid), aerobically at 37°C and 200 rpm.
A DNA fragment containing the pgdA gene (lmo0415) and its promoter was generated by PCR using oligonucleotides lmo0415-1 (5′-AAGGATCCCACAATATGTTAGTTTTCAGGGG-3′) and lmo0415-2 (5′-AAGGATCCTTATTTCACCATTCTTGAATCTG-3′). The fragment was integrated into pCR-Blunt-II-TOPO (Invitrogen) and the construct was verified by sequencing. After digestion of the construct by BamHI, the fragment was purified on agarose gel and cloned into the integrative vector pPL2 , previously digested by BamHI, constructing pOD98. The pOD98 was electroporated into ΔpgdA at 2,500 V, 200 Ω and 25 µF. Transformants were selected at 37°C on BHI agar containing chloramphenicol (7 µg/mL). The presence of the pgdA gene in the complemented strain was confirmed by PCR using oligonucleotides lmo0415-1 and lmo0415-2.
Mice were used for obtaining peptone-elicited peritoneal macrophages, resident peritoneal macrophages and bone marrow-derived macrophages. Animal experiments were performed in accordance with protocols approved by the Animal Experimentation Ethics Committee of the Institut Pasteur (permit #03-49) and following Austrian law in accordance with protocols approved by the Ethics Committee of the University of Veterinary Medicine, Vienna (#GZ680 205/67-BrGt/2003).
PEM were isolated from 7 to 10 week-old C57BL/6J and genetically-matched tlr2−/−, tlr3−/−, tlr4−/−, mal/tirap−/−, trif−/−, irf3−/− and irf7−/− mice as previously described . The percentage of macrophages was determined by flow cytometry using CD11b (1100, eBiosciences) and F4/80 (1100, eBiosciences) antibodies. More than 90% of the cells were macrophages. PEM were seeded onto 6-well plates at a concentration of 2×106 cells per well in DMEM (PAA) supplemented with 10% FCS, 10% L929 conditioned medium (LCM) and 1% penicillin-streptomycin or RPMI-1640 (Gibco) supplemented with 10% FBS and 1% penicillin-streptomycin.
Resident macrophages were isolated from 6 to 8 week-old C57BL/6J and genetically-matched tlr2−/−, trif−/− mice by washing the peritoneum twice with 10 mL DMEM (PAA) supplemented with 10% FBS, 10% LCM and 1% penicillin-streptomycin. Harvested cells were centrifuged at 300 g for 5 minutes and resuspended in complete medium. The percentage of macrophages was determined by flow cytometry analysis as above. Cells were seeded onto 6-well plates (Nunc) at a concentration of 2×106 cells per well.
Tibia and femur from 6 to 8 week-old C57BL/6J and genetically-matched tlr2−/−, trif−/− mice were collected in ice cold PBS. Bones were sterilized with 70% ethanol and flushed with a 25-G needle using cold DMEM supplemented with 10% FCS, 10% LCM and 1% penicillin-streptomycin. Cells were seeded onto 6-well plates (Nunc) at a concentration of 106 cells per well and incubated at 37°C with 5% CO2. After 4 days, complete medium was added and cells were split at a ratio of 12. After 8 days, macrophages were fully differentiated.
Human acute monocytic leukemia THP-1 cells (ATCC TIB202) were maintained in RPMI-1640 supplemented with 10% FBS and 1% penicillin-streptomycin. Cells were seeded onto a 24-well plate at a concentration of 4×105 cells per well in antibiotic-free media supplemented with 12.5 ng/mL phorbol myristate acetate and incubated for 24 h at 37°C with 5% CO2. Differentiation was determined to be successful upon formation of a confluent adherent monolayer. HEK-blue type I IFN cells (Invivogen) were grown in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. Cells were seeded at a concentration of 5.6×104 cells per well onto a 96-well plate.
For cytokine analysis, macrophages were infected with Listeria strains at MOI 101, centrifuged at 300 g for 2 min and incubated at 37°C for 15 min. Following phagocytosis, monolayers were washed twice followed by incubation in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and gentamicin (20 µg/mL). Supernatants were collected at various time points, for detection of IFN-β by ELISA. For transcript analysis, macrophages were infected with Listeria strains at MOI 201 and incubated at 37°C for 1 h to allow phagocytosis. Monolayers were washed and incubated in DMEM supplemented with 10% FCS and gentamicin (5 µg/mL). After 2 h, medium was changed to DMEM supplemented with 10% FCS and gentamicin (1 µg/mL). Cells were lysed at various time points and RNA collected for qPCR analysis.
For inhibition of bacterial internalization, cell monolayers were pretreated either for 2 h with 100 µM cytochalasin-D (Sigma-Aldrich), or 30 min with 80 µM dynasore (Sigma-Aldrich) or 30 min with 100 µM chloroquine (Sigma-Aldrich) prior to infection assays.
Listeria were grown overnight in BHI at 37°C and cultures were centrifuged at 8000 g for 5 min. Bacterial pellets were resuspended in 75 µg/mL lysozyme and incubated at 37°C for 1 h. DNA was then extracted using the DNeasy blood and tissue kit (Qiagen) and quantified by spectrophotometry (Nanodrop). For transfection assays, THP-1 macrophages were transfected with 200 ng/mL DNA with 2% lipofectamine 2000 (Invitrogen) and incubated for 24 h. Following incubation, supernatants were collected for IFN-β analysis. For pretreatment of DNA with DNase, DNase was added at final concentration of 100 µg/mL for 45 min at 37°C.
Bacterial cultures were treated with 10 µg/mL lysozyme, a concentration leading to lysis of ΔpgdA but not EGDe, and incubated at 37°C and 200 rpm for 1 h. Following lysozyme treatment, lysed bacterial cultures were centrifuged at 5000 rpm during 10 min. Two types of experiments were performed on supernatants. First, nucleic acid release was quantified. DNA was purified using the Qiagen DNeasy blood and tissue kit omitting lysis steps and quantified by spectrophotometry (Nanodrop). RNA was purified using Qiagen RNeasy kit and quantified by spectrophotometry (Nanodrop). Data shown are representatives of at least three independent experiments. Second, 100 µL of each supernatants were treated by DNase during 30 min at 37°C. Enzymes were inactivated and treated- or untreated-supernatants were transfected in PEM. 8 h after transfection, supernatants of cells were recovered and the IFNβ was quantified.
Murine IFN-β production was detected in macrophage supernatants by ELISA according to the manufacturer's procedure (PBL Biomedical Laboratories). For the HEK-blue type I IFN assay, supernatant from THP-1 macrophage assays was collected and 20 µL added onto HEK-blue type I IFN cells plated in 96-well plates, which were incubated at 37°C overnight. Supernatant from HEK-blue cells was collected and 40 µL added to 160 µL of Quanti-blue reagent (Invivogen) for 20 min at 37°C. The colorimetric reaction was measured at 625 nm on a plate reader. Data was normalised against absorbance for the untreated cells and plotted as relative fold increases. Data shown are representatives of at least three independent experiments.
PEM from WT or tlr2−/− C57BL/6J mice were infected with EGDe. Cells were lysed 0, 0.5, 1, 1.5, 2, 2.5, or 3 h post-infection. IκB and tubulin were detected in lysates by immunoblotting using anti-IκB (Santa Cruz, 1100) and anti-α-tubulin (Sigma, 15000) antibodies.
RNA preparation was performed using NucleoSpin RNA II kit (Macherey-Nagel) according to the manufacturer's instructions. Quantitative real-time PCR was performed on a Mastercycler EP realplex S (Eppendorf). Primers for HPRT (housekeeping gene control), IFNβ and IκBα mRNA expression were as follows: HPRT forward GTTGGATACAGGCCAGACTTTGTTG, HPRT reverse GAGGGTAGGCTGGCCTATTGGCT, IFNβ forward 5′-TCAGAATGAGTGGTGGTTGC-3′, IFNβ reverse 5′-GACCTTTCAAATGCAGTAGATTCA-3′; IκBα forward 5′-GCAATTTCTGGCTGGTGGG-3′, IκBα reverse 5′GATCCGCCAGGTGAAGGG-3′. Data shown are representatives of at least three independent experiments.
Results are expressed as means of at least three values, with error bars representing standard deviations. Student's t tests were performed to determine statistical significance where * indicates P<0.05, ** indicates P<0.01 and *** indicates P<0.0001.
TRIF is not required for IFN-β response to Listeria in bone marrow macrophages. BMM from C57BL/6J or trif−/− mice were infected with the parental EGDe strain (black bars) or the ΔpgdA mutant (grey bars). After 4 h of infection, IFN-β induction was measured by qRT-PCR. Data are mean ± SD (NS, non significant, n=3).
TLR2 is required for optimal activation of NF-κB. (A) PEM from WT C57BL/6J mice were infected with EGDe. Cells were lysed 0, 0.5, 1, 1.5, 2, 2.5, or 3 h post-infection. Activation of NF-κB was measured by determination of IκB degradation relative to tubulin following immunodetection. (B) PEM from tlr2−/− mice were infected with EGDe. Cells were lysed 0, 0.5, 1, 1.5, 2, 2.5, or 3 h post-infection. Activation of NF-κB was measured by determination of IκB degradation relative to tubulin following immunodetection.
We thank members of the Cossart laboratory for helpful discussions.
Competing Interests: The authors have declared that no competing interests exist.
Funding: Work in PC's laboratory received financial support from Institut Pasteur (http://www.pasteur.fr), Inserm (http://www.inserm.fr), INRA (http://www.inra.fr), ERC (Advanced Grant 233348, http://erc.europa.eu/), Fondation Pasteur-Weizmann and Fondation le Roch Les Mousquetaires (http://www.fondationleroch-lesmousquetaires.org/). PC is an international research scholar of the Howard Hughes Medical Institute (http://www.hhmi.org/). CA is a doctoral fellow of the Ministère de l'Enseignement Supérieur et de la Recherche. Work in LO's laboratory was supported by Science Foundation Ireland (http://www.sfi.ie/) and the Irish Research Council for Science, Engineering and Technology (RS/2005/190, http://www.ircset.ie/). Work in TD's laboratory was funded by the Austrian Research Foundation (grants SFB-28 and P20522-B05, http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.